Pharmalot By Ed Silverman Pharmalot, Pharmalittle: FTC is ‘aware’ of concerns over possible Mylan antitrust violations
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Glaxo CEO looks for drug prices to fall no matter who is president
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Valeant sued by Sprout investors over female libido pill
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Pfizer pays $14 billion for Medivation and its prostate cancer drug
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Valeant under criminal investigation for defrauding insurers
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Valeant reorganizes and maintains earnings forecast
The Pharmalot View By Ed Silverman Pharma trade group says price gougers are outliers, but then accepts two more
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: FDA overlooks troubles at Chinese supplier to avoid shortages
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Novartis stops making TB drugs in Pakistan, prompting fear of a health crisis
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: FDA reviewers say Valeant drug carries suicide risks
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Medivation to start takeover talks with Sanofi and others
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: India inspects 200 drug makers for poor-quality meds